🐭 RAT series
Points to Ponder for NEET-PG, FMGE & NEXT
- Hyperacute rejection is the most severe and occurs rapidly due to pre-existing ABO incompatibility or anti-HLA antibodies.
- Acute cellular rejection involves T cell infiltration and can be reversible with treatment.
- Acute antibody-mediated rejection involves antibody attack on the graft endothelium and is characterized by C4d deposition.
- Chronic rejection is characterized by progressive fibrosis and loss of function in the graft.
Graft rejection is the immune system’s attack on a transplanted organ or tissue. The type of rejection can be classified based on the timing of onset and the mechanisms involved.
Hyperacute Rejection:
- Occurs within minutes to hours after transplantation.
- Most commonly caused by:
- ABO blood group incompatibility: Pre-existing antibodies against A or B antigens on the donor organ.
- Pre-formed anti-HLA antibodies: Recipient has antibodies against donor’s Human Leukocyte Antigen (HLA) molecules.
- Pathogenesis:
- Antibodies activate the complement system.
- Complement fragments deposit on blood vessel walls in the graft, leading to thrombosis (blood clot formation) and tissue damage.
- Clinical features: Rapid decline in graft function.
- Kidney involvement: Graft becomes cyanotic (bluish), mottled (discolored), and flaccid (limp).
Acute Rejection:
- Occurs within the first 6 months post-transplant.
- Two main types:
- Acute Cellular Rejection (T cell-mediated):
- Caused by T lymphocytes directly attacking the graft tissue.
- Characterized by infiltration of the graft with mononuclear cells (lymphocytes and macrophages).
- Usually reversible with prompt treatment.
- May present as tubulitis: inflammation of the renal tubules, with involvement of both CD4+ and CD8+ T cells, and endothelial cells (lining of blood vessels).
- Acute Antibody-mediated Rejection:
- Caused by antibodies against the graft endothelium (lining of blood vessels).
- Lesions involve inflammation of glomeruli (kidney filtering units) and peritubular capillaries (tiny blood vessels around tubules).
- Characterized by deposition of C4d, a complement breakdown product, on the graft tissue.
- Acute Cellular Rejection (T cell-mediated):
Chronic Rejection:
- Most common type of graft rejection.
- Develops months to years after transplantation (usually after 6 months).
- Pathogenesis: Gradual fibrotic scarring of the graft due to various factors, including:
- Chronic immune response.
- Ischemia (reduced blood flow) to the graft.
- Calcineurin inhibitor toxicity (medications used to suppress the immune system).
- Kidney involvement:
- Glomerulopathy: Abnormalities of the glomeruli, including duplication of the basement membrane.
- Peritubular capillaritis: Inflammation of small blood vessels around tubules, with thickening of their basement membranes.
- Interstitial fibrosis and tubular atrophy: Progressive scarring and wasting away of the functional tissue in the kidney.